The Marketing Authorization Application (MAA) for SB5, an adalimumab biosimilar candidate referencing Humira®1, has been accepted for review by the...
Read moreShire plc announced it has agreed to license global rights to all indications for PF-00547659 from Pfizer Inc. ...
Read moreMerck, a leading science and technology company, announced an increased commitment to its corporate venture fund under the new Merck...
Read moreGlaxoSmithKline and Innoviva, Inc announced that GlaxoSmithKline plc (GSK) presented new data at the American Thoracic Society (ATS) Conference from...
Read moreAllergan plc launched IBSDonTract.com, an online resource for those living with irritable bowel syndrome with diarrhea (IBS-D). IBS-D, which affects...
Read morePfizer Inc announced the European Medicines Agency (EMA) has accepted the Marketing Authorization Application (MAA) for TRUMENBA® (Meningococcal Group B...
Read moreSubjects received one-time administration of a highly optimized gene therapy at initial low dose without the need for immunosuppression Therapeutic...
Read more• Fortifying Heart Failure clinical evidence and patient quality of life (FortiHFy) is an umbrella clinical program comprising over 40...
Read more• 14 avelumab abstracts at ASCO 2016 highlight significant progress being made by the collaboration between Merck KGaA, ...
Read more• First data from two treatment-free remission (TFR) studies of Ph+ CML patients treated with Tasigna®both in front-line and second-line...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
